(Q50849562)

24 March 2018

title

Colorimetric assessment of BCR-ABL1 transcripts in clinical samples via gold nanoprobes. (English)

1 reference

24 March 2018

author

Alexandra R. Fernandes

6

1 reference

24 March 2018

Pedro Baptista

7

1 reference

24 March 2018

Raquel Vinhas

object named as

Raquel Vinhas

1

0 references

author name string

Cláudia Correia

2

1 reference

24 March 2018

Patricia Ribeiro

3

1 reference

24 March 2018

Alexandra Lourenço

4

1 reference

24 March 2018

Aida Botelho de Sousa

5

1 reference

24 March 2018

language of work or name

English

0 references

publication date

25 May 2016

1 reference

24 March 2018

Analytical and Bioanalytical Chemistry

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

24 March 2018

volume

408

1 reference

24 March 2018

issue

19

1 reference

24 March 2018

page(s)

5277-5284

1 reference

24 March 2018

Gold nanoprobe-based non-crosslinking hybridization for molecular diagnostics.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

Noble metal nanoparticles for biosensing applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

RNA quantification using gold nanoprobes - application to cancer diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

Chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

Dynamics of chronic myeloid leukemia response to long-term targeted therapy reveal treatment effects on leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

BCR-ABL transcript dynamics support the hypothesis that leukemic stem cells are reduced during imatinib treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

Atypical BCR-ABL mRNA transcripts in adult Acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

Philadelphia chromosome positive myelodysplastic syndrome and acute myeloid leukemia-retrospective study and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

Flow cytometric immunobead assay for the detection of BCR-ABL fusion proteins in leukemia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

Philadelphia-positive leukemia: a personal perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

Correlation between the type of bcr-abl transcripts and blood cell counts in chronic myeloid leukemia - a possible influence of mdr1 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

Sudden onset of the blastic phase of chronic myelogenous leukemia: patterns and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

Molecular diagnosis and monitoring in the clinical management of patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

A review of the European LeukemiaNet recommendations for the management of CML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

Malignant hematopoietic cell lines: in vitro models for the study of myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

Expansion of cancer care and control in countries of low and middle income: a call to action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

Chronic myeloid leukemia data from India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

Improving access to care in low and middle-income countries: institutional factors related to enrollment and patient outcome in a cancer drug access program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

Fused transcript of abl and bcr genes in chronic myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9622-9

10.1007/S00216-016-9622-9

21 January 2018

Identifiers

DOI

1 reference

24 March 2018

1 reference

24 March 2018